| Mrs Ellen Deann Shipp, LCSW | |
|
1049 North Pine Rd, Suite D, Olla, LA 71465-4804 | |
| (318) 495-0758 | |
| (318) 495-0751 |
| Full Name | Mrs Ellen Deann Shipp |
|---|---|
| Gender | Female |
| Speciality | Clinical Social Worker |
| Experience | 21 Years |
| Location | 1049 North Pine Rd, Olla, Louisiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740737220 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 11525 (Louisiana) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lasalle Parish Hospital Service District 1 | 6709781545 | 37 |
News Archive
Cardio3 BioSciences, a leading Belgian biotechnology company specialising in regenerative therapies for the treatment of cardiovascular disease, today announces that the key scientific work underlying its lead pharmaceutical product C-Cure(R), a revolutionary stem cell treatment for heart failure, has been published in the Journal of the American College of Cardiology (JACC). The findings were described as "landmark work" in the accompanying editorial in today's publication.
The Obama administration and its opponents in implementing the health law are readying to launch ad campaigns aimed at getting people to sign up for or stay away from new online health insurance exchanges that open Oct. 1. Many of the ads are airing in swing states, but they are also aimed at the young and uninsured in California and Texas who are uninsured in the largest numbers.
Although bone marrow transplants have long been standard for acute leukemia, current treatments still rely on exact matches between donor and patient. Now, scientists at the University of Perugia, Italy, and the Weizmann Institute of Science have improved on a method of transplanting bone marrow-based stem cells from a mismatched donor, making it safer for use when no exact match exists.
A UConn research team has found a way to stabilize hemoglobin, the oxygen carrier protein in the blood, a discovery that could lead to the development of stable vaccines and affordable artificial blood substitutes.
› Verified 2 days ago
| Entity Name | Lasalle Parish Hospital Service District #1 |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184815466 PECOS PAC ID: 6709781545 Enrollment ID: O20040408000438 |
News Archive
Cardio3 BioSciences, a leading Belgian biotechnology company specialising in regenerative therapies for the treatment of cardiovascular disease, today announces that the key scientific work underlying its lead pharmaceutical product C-Cure(R), a revolutionary stem cell treatment for heart failure, has been published in the Journal of the American College of Cardiology (JACC). The findings were described as "landmark work" in the accompanying editorial in today's publication.
The Obama administration and its opponents in implementing the health law are readying to launch ad campaigns aimed at getting people to sign up for or stay away from new online health insurance exchanges that open Oct. 1. Many of the ads are airing in swing states, but they are also aimed at the young and uninsured in California and Texas who are uninsured in the largest numbers.
Although bone marrow transplants have long been standard for acute leukemia, current treatments still rely on exact matches between donor and patient. Now, scientists at the University of Perugia, Italy, and the Weizmann Institute of Science have improved on a method of transplanting bone marrow-based stem cells from a mismatched donor, making it safer for use when no exact match exists.
A UConn research team has found a way to stabilize hemoglobin, the oxygen carrier protein in the blood, a discovery that could lead to the development of stable vaccines and affordable artificial blood substitutes.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Ellen Deann Shipp, LCSW 1049 North Pine Rd, Suite D, Olla, LA 71465-4804 Ph: (318) 495-0758 | Mrs Ellen Deann Shipp, LCSW 1049 North Pine Rd, Suite D, Olla, LA 71465-4804 Ph: (318) 495-0758 |
News Archive
Cardio3 BioSciences, a leading Belgian biotechnology company specialising in regenerative therapies for the treatment of cardiovascular disease, today announces that the key scientific work underlying its lead pharmaceutical product C-Cure(R), a revolutionary stem cell treatment for heart failure, has been published in the Journal of the American College of Cardiology (JACC). The findings were described as "landmark work" in the accompanying editorial in today's publication.
The Obama administration and its opponents in implementing the health law are readying to launch ad campaigns aimed at getting people to sign up for or stay away from new online health insurance exchanges that open Oct. 1. Many of the ads are airing in swing states, but they are also aimed at the young and uninsured in California and Texas who are uninsured in the largest numbers.
Although bone marrow transplants have long been standard for acute leukemia, current treatments still rely on exact matches between donor and patient. Now, scientists at the University of Perugia, Italy, and the Weizmann Institute of Science have improved on a method of transplanting bone marrow-based stem cells from a mismatched donor, making it safer for use when no exact match exists.
A UConn research team has found a way to stabilize hemoglobin, the oxygen carrier protein in the blood, a discovery that could lead to the development of stable vaccines and affordable artificial blood substitutes.
› Verified 2 days ago